Celebrating the Visionaries of Tomorrow
Innovation is the heartbeat of progress, and at Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), this ethos is embodied through the annual Regeneron Prize for Creative Innovation. This prestigious award, now in its 13th year, serves to recognize the exceptional creativity and talent displayed by early-career scientists in the field of biomedical research. Each year, top universities from across the United States nominate their most promising graduate students and postdoctoral fellows for this esteemed honor, emphasizing a commitment to advancing scientific frontiers.
This Year’s Trailblazers
The Regeneron Prize for Creative Innovation showcases the brightest minds, and the winners for this year are no exception. Alissandra L. Hillis, Ph.D., and Sreekar Mantena have emerged as the standout stars of this year’s competition. Dr. Hillis, a postdoctoral fellow at the Massachusetts Institute of Technology, is actively engaged in pioneering research that delves into the limits of cell proliferation through metabolism. Her work not only highlights scientific excellence but also targets pressing health issues like endometriosis, providing hope through innovative approaches.
On the other hand, Mr. Mantena, an M.D.-Ph.D. candidate in the joint Harvard-MIT program, is making strides by applying cutting-edge single-cell genomics to understand the adaptive immune system better. His work on thymic competence is crucial in exploring how age impacts immune functionality, which could potentially lead to breakthroughs in treating age-related diseases.
A Commitment to Future Innovators
According to George D. Yancopoulos, M.D., Ph.D., the Board co-Chair, President, and Chief Scientific Officer at Regeneron, the Regeneron Prize not only encourages innovation but also inspires young scientists to confront significant challenges faced by society today. With a financial reward of $50,000 and additional grants supporting their institutions, winners like Hillis and Mantena are equipped to push the envelope of biomedical research further.
Beyond rewarding individuals, Regeneron’s mission is centered on fostering a culture of integrity and excellence. The prize promotes a spirit of inquiry, urging participants to solve pressing problems through creativity and practical design in their research proposals. David J. Glass, M.D., Vice President of Research at Regeneron, emphasizes the importance of originality in research that aligns with real-world medical questions.
Empowering the Next Generation
At the core of Regeneron’s operations lies a profound commitment to social responsibility and STEM education. Through various initiatives, including flagship programs like the Regeneron Science Talent Search and the Regeneron International Science & Engineering Fair, the organization has reached over 3.25 million students since 2020, showcasing its dedication to nurturing future innovators. Regeneron’s initiatives are designed to inspire students to pursue careers in STEM, proving that creativity in science can lead to transformative solutions.
The call for nominations for the Regeneron Prize occurs each December, where institutions are encouraged to submit applications from their promising graduate students and postdoctoral fellows. Along with their applications, nominees must submit a curriculum vitae and a collection of their notable publications, allowing the selection committee to assess their contributions to the scientific community.
About Regeneron Pharmaceuticals
Regeneron (NASDAQ: REGN) has made significant advancements in biotechnology, innovating and commercializing medicines that address severe diseases. With a robust pipeline of product candidates and approved treatments, Regeneron focuses on diverse areas, including oncology, cardiovascular, and neurologic disorders. The company’s unwavering commitment to research, combined with a dedication to corporate responsibility, ensures that it not only enhances patient lives but also contributes positively to global health.
Furthermore, Regeneron’s presence on the Dow Jones Sustainability World Index and the Civic 50 list exemplifies its standing as a model corporate citizen. The organization remains committed to philanthropy, particularly in the realm of early science education, ensuring that it plays a pivotal role in shaping future generations of scientists.
Frequently Asked Questions
What is the Regeneron Prize for Creative Innovation?
The Regeneron Prize for Creative Innovation is an award that recognizes early-career scientists in biomedical research for their extraordinary creativity and talent.
Who were the winners of the 2025 Regeneron Prize?
The winners of the 2025 Regeneron Prize are Alissandra L. Hillis, Ph.D., and Sreekar Mantena.
What is the significance of the Regeneron Prize?
The Regeneron Prize supports and encourages promising scientists to pursue innovative research projects that tackle significant medical challenges.
How does Regeneron support STEM education?
Regeneron is dedicated to promoting STEM education through initiatives like the Regeneron Science Talent Search and various outreach programs for students.
How can institutions apply for the Regeneron Prize?
Institutions can submit nominations for the Regeneron Prize each December, involving graduate students and postdoctoral fellows with their project proposals.
